 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
3/13/20 Aclaris Therapeutics, Inc. S-3 7:1.5M Toppan Merrill/FA
3/13/20 Aclaris Therapeutics, Inc. 8-K:1,9 3/13/20 2:251K Toppan Merrill/FA
3/13/20 SEC UPLOAD¶ 5/7/20 2:48K Cal-Maine Foods Inc.
3/13/20 SEC UPLOAD¶ 5/15/20 2:45K Aurora Cannabis Inc.
3/13/20 SEC UPLOAD¶ 4/10/20 2:39K Carrier Global Corp.
3/13/20 SEC UPLOAD¶ 4/29/20 2:50K Chemours Co.
3/13/20 SEC UPLOAD¶ 5/12/20 2:51K Exterran Corp.
EES Finance Corp.
Exterran Energy Solutions, L.P.
3/13/20 SEC UPLOAD¶ 10/14/20 2:48K StepStone Group Inc.
3/13/20 SEC UPLOAD¶ 5/4/20 2:48K Sphere Entertainment Co.
3/13/20 SEC UPLOAD¶ 4/10/20 2:39K Stride, Inc.
3/13/20 SEC UPLOAD¶ 4/10/20 2:45K Maximus, Inc.
3/13/20 SEC UPLOAD¶ 4/10/20 2:44K Otis Worldwide Corp.
3/13/20 SEC UPLOAD¶ 4/15/20 2:39K Seres Therapeutics, Inc.
3/13/20 SEC UPLOAD¶ 4/10/20 2:39K AutoZone, Inc.
3/13/20 SEC UPLOAD¶ 4/21/20 2:47K Amcor UK Finance plc
Amcor Finance (USA), Inc.
Amcor Ltd.
Amcor plc
Bemis Co. Inc.
3/13/20 SEC UPLOAD¶ 12/23/20 2:60K iCap Vault 1, LLC
| ____________ | | ¹ | Filing/Form Types: -A | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | S-3 | Registration Statement – Securities for a Transaction — Form S-3. | | UPLOAD | Comment or Other Letter from the SEC. | | ¶ | This Filing contains a delayed-release Document. |
|
